Results 101 to 110 of about 37,026 (217)

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

open access: yesBritish Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli   +7 more
wiley   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus   +5 more
wiley   +1 more source

Sigara bırakma tedavisi sırasında Bupropion Hcl’e bağlı gelişen serum hastalığı benzeri reaksiyon: Olgu sunumu

open access: yesTurkish Journal of Family Practice, 2017
Dünyada önlenebilir erken ölüm ve sakatlık nedenlerinin başında sigara kullanımı yer almaktadır. Nikotin replasman tedavisi (NRT), vareniklin ve bupropion HCL başlıca sigara bırakma ilaçlarıdır.
Ruhuşen Kutlu   +2 more
doaj   +1 more source

Methylphenidate, Bupropion, and SSRI Triple Therapy [PDF]

open access: yes, 2012
Methylphenidate and bupropion have been demonstrated as being effective adjuncts to serotonin reuptake inhibitors in the treatment of depression (1,2). The use of these medications in case of a depressed patient whose condition was resistant to several ...
Bobo, William, M.D.
core   +1 more source

The real‐world relationship between naltrexone/bupropion treatment and weight loss in Canada: A retrospective chart review

open access: yesClinical Obesity, Volume 15, Issue 2, April 2025.
Summary This study examined the change in weight at 6 months of naltrexone/bupropion (NB), a combination pharmacological therapy for weight management, in real‐world practice in Canada. The study was conducted through an observational, retrospective, single‐arm chart review of adult patients who attended the Wharton Medical Clinic in Ontario, Canada ...
Sean Wharton   +4 more
wiley   +1 more source

Bupropion Shows Different Effects on Brain Functional Connectivity in Patients With Internet-Based Gambling Disorder and Internet Gaming Disorder

open access: yesFrontiers in Psychiatry, 2018
IntroductionInternet gaming disorder (IGD) and gambling disorder (GD) share similar clinical characteristics but show different brain functional connectivity patterns. Bupropion is known to be effective for the treatment of patients with IGD and GD.
Sujin Bae   +3 more
doaj   +1 more source

Sodium‐glucose co‐transporter 2 inhibitors and obesity‐associated cancers in people with type 2 diabetes: A real‐world observational study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To investigate the association between sodium‐glucose co‐transporter 2 inhibitors (SGLT‐2i) and obesity‐associated cancers (OAC) in individuals with type 2 diabetes (T2D). Materials and Methods This retrospective cohort study used data from the TriNetX US Collaborative Network.
Testimony Ipaye   +8 more
wiley   +1 more source

Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trial

open access: yesDigital Health
Background Although smartphone application for smoking cessation was considered a promising strategy, there were scarce studies on the combination of usual interventions and apps for smoking cessation in China. Our study aimed to evaluate the efficacy of
Xiao-Wen Wei   +11 more
doaj   +1 more source

SAL0114: a novel deuterated dextromethorphan-bupropion combination with improved antidepressant efficacy and safety profile

open access: yesFrontiers in Pharmacology
BackgroundEsketamine, the first Food and Drug Administration-approved fast-acting antidepressant, has limited use because of its addictive properties.
Ying Xiao   +9 more
doaj   +1 more source

Bupropion use: Psychotic relapse versus smoking cessation

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Bupropion, a first-line pharmacological treatment for nicotine addiction, is a reuptake inhibitor of dopamine and norepinephrine. Dopaminergic effects of bupropion may cause or worsen psychosis. We reported a case with schizoaffective disorder (SD), who
Atakan Yücel   +4 more
doaj  

Home - About - Disclaimer - Privacy